The isomeric first excited state of the isotope 229Th exhibits the lowest nuclear excitation energy in the whole landscape of known atomic nuclei. For a long time this energy was reported in the literature as 3.5(5) eV, however, a new experiment corr
ected this energy to 7.6(5) eV, corresponding to a UV transition wavelength of 163(11) nm. The expected isomeric lifetime is $tau=$ 3-5 hours, leading to an extremely sharp relative linewidth of Delta E/E ~ 10^-20, 5-6 orders of magnitude smaller than typical atomic relative linewidths. For an adequately chosen electronic state the frequency of the nuclear ground-state transition will be independent from influences of external fields in the framework of the linear Zeeman and quadratic Stark effect, rendering 229mTh a candidate for a reference of an optical clock with very high accuracy. Moreover, in the literature speculations about a potentially enhanced sensitivity of the ground-state transition of $^{229m}$Th for eventual time-dependent variations of fundamental constants (e.g. fine structure constant alpha) can be found. We report on our experimental activities that aim at a direct identification of the UV fluorescence of the ground-state transition energy of 229mTh. A further goal is to improve the accuracy of the ground-state transition energy as a prerequisite for a laser-based optical control of this nuclear excited state, allowing to build a bridge between atomic and nuclear physics and open new perspectives for metrological as well as fundamental studies.
We study the production of radioisotopes for nuclear medicine in (gamma,gamma) photoexcitation reactions or (gamma,xn + yp) photonuclear reactions for the examples of ^195mPt, ^117mSn and ^44Ti with high flux [(10^13 - 10^15) gamma/s], small beam dia
meter and small energy band width (Delta E/E ~ 10^-3 -10^-4) gamma beams. In order to realize an optimum gamma-focal spot, a refractive gamma-lens consisting of a stack of many concave micro-lenses will be used. It allows for the production of a high specific activity and the use of enriched isotopes. For photonuclear reactions with a narrow gamma beam, the energy deposition in the target can be reduced by using a stack of thin target wires, hence avoiding direct stopping of the Compton electrons and e^+e^- pairs. The well-defined initial excitation energy of the compound nucleus leads to a small number of reaction channels and enables new combinations of target isotope and final radioisotope. The narrow-bandwidth gamma excitation may make use of collective resonances in gamma-width, leading to increased cross sections. (gamma,gamma) isomer production via specially selected gamma cascades allows to produce high specific activity in multiple excitations, where no back-pumping of the isomer to the ground state occurs. The produced isotopes will open the way for completely new clinical applications of radioisotopes. For example ^195mPt could be used to verify the patients response to chemotherapy with platinum compounds before a complete treatment is performed. In targeted radionuclide therapy the short-range Auger and conversion electrons of ^195mPt and ^117mSn enable a very local treatment. The generator ^44Ti allows for a PET with an additional gamma-quantum (gamma-PET), resulting in a reduced dose or better spatial resolution.